Compare 10X Genomics Inc (TXG) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Valero Energy Corporation — how do they compare? 10X Genomics Inc trades at $47.2 (market cap $5.48B), while Valero Energy Corporation trades at $313.64 (market cap $93.03B). The key difference: Valero Energy Corporation is far larger — about 17× 10X Genomics Inc's market cap, and Valero Energy Corporation pays a 1.53% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | VLO | |
|---|---|---|
Market Cap | $5.48B | $93.03B |
Sector | Health | Energy |
52-Week High | $45.80 | $313.31 |
52-Week Low | $11.34 | $131.77 |
Enterprise Value | $5.02B | $98.79B |
Dividend Yield | — | 1.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TXG trades at $47.20, up 7.91% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue that beat estimates, and net losses have narrowed significantly from -$255M in 2023 to -$44M in 2025. Operating cash flow turned strongly positive at $136M in 2025. Recent developments include the acquisition of Proteintech Genomics and a collaboration with Cleveland Clinic on bladder cancer diagnostics.
The outlook is mixed; improving fundamentals and strategic expansions support growth, but persistent net losses and a high EV/EBITDA of 133.91 pose valuation risks. Analyst consensus is divided with a $39.14 price target below the current price, indicating caution despite a majority buy/hold ratings.
Valero Energy (VLO) trades at $314.80, up 1.66% today and near its 52-week high, with a bullish technical outlook supported by strong moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 expected at $10.13 EPS. Revenue declined to $122.69B in 2025, but net income margin improved to 3.37%, while valuation ratios like P/E of 22.89 and P/S of 0.77 reflect moderate pricing relative to peers. Recent news highlights robust refining margins and dividend declarations of $1.20 per share.
VLO's outlook is positive due to elevated crack spreads and strong fuel demand, though revenue declines pose a risk. Analyst consensus is bullish with a $285.38 price target, but high RSI levels suggest potential near-term pullbacks. Investment appeal lies in earnings momentum and shareholder returns, balanced against exposure to volatile energy markets and refining margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
